首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD22 Recombinant Antibody(Epratuzumab)

Anti-Human CD22 Recombinant Antibody(Epratuzumab)

产品编号

YR1021

别名

科研级 Epratuzumab ( 依帕珠单抗 ), Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab

规格
  • 1mg
  • 5mg
产品介绍
Alias科研级 Epratuzumab ( 依帕珠单抗 ), Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab
Catalog NumberYR1021
Molecular NameEpratuzumab
HostMouse
Size1mg, 5mg
ClonityMonoclonal
Purity>95% as determined by SDS-PAGE
Concentration1mg/ml
Antibody IsotypeIgG1
FormulationPBS, pH7.5
BackgroundEpratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE).
CAS Number205923-57-5
ApplicationIF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
RemarksThis product is for research use only.
Shipping ConditionShipped on ice packs.
TargetCD22[Homo sapiens]

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价